MOSUNETUZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 13:40:37 UTC 2023` Edited by `admin` on `Sat Dec 16 13:40:37 UTC 2023`
Protein Type	BISPECIFIC ANTIBODY
Protein Sub Type	IMMUNOMODULATOR
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	LDJ89SS0YG
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

MOSUNETUZUMAB

Official Name

English

RG-7828

Code

English

BTCT-4465A

Code

English

MOSUNETUZUMAB [USAN]

Common Name

English

Mosunetuzumab [WHO-DD]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA ANTI-(HOMO SAPIENS T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN (CD3E ANTIGEN)) AND IMMUNOGLOBULIN G1-KAPPA ANTI-(HOMO SAPIENS B-LYMPHOCYTE ANTIGEN CD20) HETERODIMERHUMANIZED MONOCLONAL ANTIBODY BISPECIFIC.GAMMA.1 HEAVY CHAIN ANT

Systematic Name

English

RO7030816

Code

English

RO-7030816

Code

English

IMMUNOGLOBULIN G1, HUMANIZED BISPECIFIC, ANTI-(HUMAN CD3 (ANTIGEN))(BTCT4465A .GAMMA.1-CHAIN), DISULFIDE WITH ANTI-(HUMAN CD3 (ANTIGEN)) BTCT4465A .KAPPA.4-CHAIN, ANTI-(HUMAN CD20 (ANTIGEN)) BTCT4465A .GAMMA.3-CHAIN AND ANTI-(HUMAN CD20 (ANTIGEN)) BTCT44

Systematic Name

English

BTCT4465A

Code

English

RG7828

Code

English

mosunetuzumab [INN]

Common Name

English

RG-7828 (ANTI-CD20 & CD3)

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

663418

Created by admin on Sat Dec 16 13:40:38 UTC 2023 , Edited by admin on Sat Dec 16 13:40:38 UTC 2023

Code System Code Type Description

FDA UNII

LDJ89SS0YG

Created by admin on Sat Dec 16 13:40:38 UTC 2023 , Edited by admin on Sat Dec 16 13:40:38 UTC 2023

PRIMARY

INN

10621

Created by admin on Sat Dec 16 13:40:38 UTC 2023 , Edited by admin on Sat Dec 16 13:40:38 UTC 2023

PRIMARY

CAS

1905409-39-3

Created by admin on Sat Dec 16 13:40:38 UTC 2023 , Edited by admin on Sat Dec 16 13:40:38 UTC 2023

PRIMARY

USAN

FG-70

Created by admin on Sat Dec 16 13:40:38 UTC 2023 , Edited by admin on Sat Dec 16 13:40:38 UTC 2023

PRIMARY

DAILYMED

LDJ89SS0YG

Created by admin on Sat Dec 16 13:40:38 UTC 2023 , Edited by admin on Sat Dec 16 13:40:38 UTC 2023

PRIMARY

NCI_THESAURUS

C129691

Created by admin on Sat Dec 16 13:40:38 UTC 2023 , Edited by admin on Sat Dec 16 13:40:38 UTC 2023

PRIMARY

DRUG BANK

DB15434

Created by admin on Sat Dec 16 13:40:38 UTC 2023 , Edited by admin on Sat Dec 16 13:40:38 UTC 2023

PRIMARY

From	To
1_22	1_96
1_149	1_205
1_266	1_326
1_372	1_430
2_22	2_96
2_146	2_202
2_263	2_323
2_369	2_427
1_225	4_213
1_231	2_228
1_234	2_231
2_222	3_219
3_23	3_94
3_139	3_199
4_23	4_87
4_133	4_193

Related Record Type Details


					TB2Q79LBS0

B-LYMPHOCYTE ANTIGEN CD20

TARGET->ANTIGEN


					TB2Q79LBS0

B-LYMPHOCYTE ANTIGEN CD20

TARGET->LIGAND

Mosunetuzumab-AXGB

SUB_CONCEPT->SUBSTANCE

Amount:


					ZLW14X2D30

CD3

TARGET -> ACTIVATOR

Related Record Type Details


					LDJ89SS0YG

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL